TTC39C inhibitors, given the current context, predominantly target pathways or processes where tetratricopeptide repeat (TPR) motif-containing proteins might play roles. TPR motifs are known to mediate protein-protein interactions and are found in a diverse range of proteins. Staurosporine, with its broad kinase inhibition spectrum, can potentially influence multiple cellular pathways, thereby affecting proteins like TTC39C.
Similarly, compounds like Rapamycin or Cyclosporine A have specific targets but can have downstream effects on various cellular proteins, including those containing TPR motifs. A focus on endocytic and protein degradation pathways, using inhibitors like Chloroquine and MG-132, offers another approach, either directly or indirectly, modulating them could influence its function.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor. By affecting protein degradation, it could have an indirect influence on TPR-containing proteins' stability and function. | ||||||